534
Views
124
CrossRef citations to date
0
Altmetric
Research Article

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

, , , , &
Pages 179-190 | Received 22 Jun 2009, Accepted 08 Sep 2009, Published online: 06 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Alireza Abdanipour, Mojgan Mirzaei, Iraj Jafari Anarkooli & Parvin Mohammadi. (2023) Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury. Neurological Research 45:3, pages 241-247.
Read now
Kunho Chung, Irfan Ullah, Nahyeon Kim, Jaeyeoung Lim, Jungah Shin, Sangah C. Lee, Sangmin Jeon, Sun Hwa Kim, Priti Kumar & Sang-Kyung Lee. (2020) Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth. Journal of Drug Targeting 28:6, pages 617-626.
Read now
Smrithi Padmakumar, Maie S. Taha, Ekta Kadakia, Benjamin S. Bleier & Mansoor M. Amiji. (2020) Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases. Expert Opinion on Drug Delivery 17:3, pages 323-340.
Read now
Amirah E-E Aly & Barbara L Waszczak. (2015) Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier. Expert Opinion on Drug Delivery 12:12, pages 1923-1941.
Read now
Ye Xiong, Yanlu Zhang, Asim Mahmood & Michael Chopp. (2015) Investigational agents for treatment of traumatic brain injury. Expert Opinion on Investigational Drugs 24:6, pages 743-760.
Read now
Sumeet Sood, Kunal Jain & K. Gowthamarajan. (2014) Intranasal therapeutic strategies for management of Alzheimer’s disease. Journal of Drug Targeting 22:4, pages 279-294.
Read now
Yun Li, Yahong Liu, Zhaojun Wang & Yongjun Jiang. (2013) Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?. Expert Opinion on Biological Therapy 13:11, pages 1515-1522.
Read now
Francesca Malerba, Francesca Paoletti, Simona Capsoni & Antonino Cattaneo. (2011) Intranasal delivery of therapeutic proteins for neurological diseases. Expert Opinion on Drug Delivery 8:10, pages 1277-1296.
Read now
Wusheng Zhu, Songming Cheng, Gelin Xu, Minmin Ma, Zhiming Zhou, Dezhi Liu & Xinfeng Liu. (2011) Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia. Drug Delivery 18:5, pages 338-343.
Read now
Yongjun Jiang, Juehua Zhu, Gelin Xu & Xinfeng Liu. (2011) Intranasal delivery of stem cells to the brain. Expert Opinion on Drug Delivery 8:5, pages 623-632.
Read now
Sermin Genc, Zeynep Zadeoglulari, Meryem Gulfem Oner, Kursad Genc & Murat Digicaylioglu. (2011) Intranasal erythropoietin therapy in nervous system disorders. Expert Opinion on Drug Delivery 8:1, pages 19-32.
Read now
Murat Digicaylioglu. (2010) Erythropoietin in stroke: quo vadis. Expert Opinion on Biological Therapy 10:6, pages 937-949.
Read now

Articles from other publishers (111)

Golnoush Mirzahosseini, Justin Mark Adam, Sanaz Nasoohi, Azza B. El-Remessy & Tauheed Ishrat. (2022) Lost in Translation: Neurotrophins Biology and Function in the Neurovascular Unit. The Neuroscientist 29:6, pages 694-714.
Crossref
Diana I. Salikhova, Victoria V. Golovicheva, Timur Kh. Fatkhudinov, Yulia A. Shevtsova, Anna G. Soboleva, Kirill V. Goryunov, Alexander S. Dyakonov, Victoria O. Mokroysova, Natalia S. Mingaleva, Margarita O. Shedenkova, Oleg V. Makhnach, Sergey I. Kutsev, Vladimir P. Chekhonin, Denis N. Silachev & Dmitry V. Goldshtein. (2023) Therapeutic Efficiency of Proteins Secreted by Glial Progenitor Cells in a Rat Model of Traumatic Brain Injury. International Journal of Molecular Sciences 24:15, pages 12341.
Crossref
S. G. Belokoskova & S. G. Tsikunov. (2023) The Neurotrophic, Neuroprotective, Mitogenic, Antioxidant, and Antiapoptotic Properties of Vasopressin. Neuroscience and Behavioral Physiology 53:4, pages 627-635.
Crossref
Jing Wang, Yichen Cai, Jingyi Sun, Hua Feng, Xiaoyu Zhu, Qian Chen, Feng Gao, Qingbin Ni, Leilei Mao, Mingfeng Yang & Baoliang Sun. (2023) Administration of intramuscular AAV-BDNF and intranasal AAV-TrkB promotes neurological recovery via enhancing corticospinal synaptic connections in stroke rats. Experimental Neurology 359, pages 114236.
Crossref
James M. Fay & Alexander V. Kabanov. (2023) Interpolyelectrolyte Complexes as an Emerging Technology for Pharmaceutical Delivery of Polypeptides. Reviews and Advances in Chemistry 12:3, pages 137-162.
Crossref
Nina Colitti, Franck Desmoulin, Alice Le Friec, Wafae Labriji, Lorenne Robert, Amandine Michaux, Fabrice Conchou, Carla Cirillo & Isabelle Loubinoux. (2022) Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue. Frontiers in Cellular Neuroscience 16.
Crossref
Elsie Chit Yu Iu & Chi Bun Chan. (2022) Is Brain-Derived Neurotrophic Factor a Metabolic Hormone in Peripheral Tissues?. Biology 11:7, pages 1063.
Crossref
Yu Wu, Miora Rakotoarisoa, Borislav Angelov, Yuru Deng & Angelina Angelova. (2022) Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery. Nanomaterials 12:13, pages 2267.
Crossref
Hugo Alarcan, Yara Al Ojaimi, Debora Lanznaster, Jean-Michel Escoffre, Philippe Corcia, Patrick Vourc’h, Christian R. Andres, Charlotte Veyrat-Durebex & Hélène Blasco. (2022) Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?. Journal of Personalized Medicine 12:7, pages 1071.
Crossref
Ewelina Bratek-Gerej, Apolonia Ziembowicz & Elzbieta Salinska. (2022) Group II Metabotropic Glutamate Receptors Reduce Apoptosis and Regulate BDNF and GDNF Levels in Hypoxic-Ischemic Injury in Neonatal Rats. International Journal of Molecular Sciences 23:13, pages 7000.
Crossref
Gordana D. Vitaliano, Jae K. Kim, Marc J. Kaufman, Christopher W. Adam, Gonzalo Zeballos, Abinaya Shanmugavadivu, Sivan Subburaju, Jay P. McLaughlin, Scott E. Lukas & Franco Vitaliano. (2022) Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model. Communications Biology 5:1.
Crossref
Yuanyuan Ma, Zhiyuan Zhou, Guo-Yuan Yang, Jing Ding & Xin Wang. (2022) The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review. Frontiers in Pharmacology 13.
Crossref
D. G. Semenov & A. V. Belyakov. (2022) BDNF and Senile Cognitive Decline. Neuroscience and Behavioral Physiology 52:2, pages 287-296.
Crossref
Lina Gao, Yun Zhang, Keenan Sterling & Weihong Song. (2022) Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential. Translational Neurodegeneration 11:1.
Crossref
Anisha A D'Souza, Shallu Kutlehria, Di Huang, Benjamin S Bleier & Mansoor M Amiji. (2021) Nasal delivery of nanotherapeutics for CNS diseases: challenges and opportunities. Nanomedicine 16:30, pages 2651-2655.
Crossref
Yu-Ting Zhang, Kai-Jie He, Jin-Bao Zhang, Quan-Hong Ma, Fen Wang & Chun-Feng Liu. (2021) Advances in intranasal application of stem cells in the treatment of central nervous system diseases. Stem Cell Research & Therapy 12:1.
Crossref
E. Ya. Shevela, V. G. Degtyareva, A. V. Sosnovskaya, E. V. Voronova, M. Yu. Kafanova, I. M. Rashchupkin, A. A. Ostanin & E. R. Chernykh. (2021) Therapeutic effect of soluble factors of M2 phenotype macrophages in children with language impairments. Medical Immunology (Russia) 23:5, pages 1137-1150.
Crossref
Gozal Bahlakeh, Reza Rahbarghazi, Daruosh Mohammadnejad, Ali Abedelahi & Mohammad Karimipour. (2021) Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches. Cell & Bioscience 11:1.
Crossref
Yuanyuan Huang, Dangwei Peng, Hao Geng, Yutian Dai, Hui Jiang & Xiansheng Zhang. (2021) Expression of brain‐derived neurotrophic factor in rapid ejaculator rats: A further study. Andrologia 53:8.
Crossref
Yuanyuan Huang, Dangwei Peng, Hao Geng, Yutian Dai, Hui Jiang & Xiansheng Zhang. (2021) Endogenous Deficiency of Brain-Derived Neurotrophic Factor Induces the Downregulation of Tryptophan Hydroxylase-2 Expression in Raphe Nuclei of Rapid Ejaculator Rats . The Journal of Sexual Medicine 18:9, pages 1491-1499.
Crossref
Jakob Norgren, Makrina Daniilidou, Ingemar Kåreholt, Shireen Sindi, Ulrika Akenine, Karin Nordin, Staffan Rosenborg, Tiia Ngandu, Miia Kivipelto & Anna Sandebring-Matton. (2021) Serum proBDNF Is Associated With Changes in the Ketone Body β-Hydroxybutyrate and Shows Superior Repeatability Over Mature BDNF: Secondary Outcomes From a Cross-Over Trial in Healthy Older Adults. Frontiers in Aging Neuroscience 13.
Crossref
Giuseppe Alastra, Luigi Aloe, Vito Antonio Baldassarro, Laura Calzà, Maura Cescatti, Jason Thomas Duskey, Maria Letizia Focarete, Daria Giacomini, Luciana Giardino, Valentina Giraldi, Luca Lorenzini, Marzia Moretti, Irene Parmeggiani, Michele Sannia & Giovanni Tosi. (2021) Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?. Frontiers in Neuroscience 15.
Crossref
Chiara Nicolini & Aimee J. Nelson. (2021) Current Methodological Pitfalls and Caveats in the Assessment of Exercise-Induced Changes in Peripheral Brain-Derived Neurotrophic Factor: How Result Reproducibility Can Be Improved. Frontiers in Neuroergonomics 2.
Crossref
Tadahiro Numakawa & Haruki Odaka. (2021) Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer’s Disease: Beneficial Effects of Flavonoids for Neuroprotection. International Journal of Molecular Sciences 22:11, pages 5719.
Crossref
Chiara Braschi, Simona Capsoni, Roberta Narducci, Andrea Poli, Gabriele Sansevero, Rossella Brandi, Lamberto Maffei, Antonino Cattaneo & Nicoletta Berardi. (2020) Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis. Aging Clinical and Experimental Research 33:5, pages 1223-1238.
Crossref
Anisha D'Souza, Kandarp M. Dave, R. Anne Stetler & Devika S. Manickam. (2021) Targeting the blood-brain barrier for the delivery of stroke therapies. Advanced Drug Delivery Reviews 171, pages 332-351.
Crossref
Elvira Brattico, Leonardo Bonetti, Gabriella Ferretti, Peter Vuust & Carmela Matrone. (2021) Putting Cells in Motion: Advantages of Endogenous Boosting of BDNF Production. Cells 10:1, pages 183.
Crossref
Keirnan Willett, Reas S. Khan, Kimberly Dine, Howard Wessel, Ziv Z. Kirshner, Jodie L. Sauer, Ashley Ellis, Larry R. Brown & Kenneth S. Shindler. (2021) Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells. PLOS ONE 16:1, pages e0243862.
Crossref
Md. Tipu Sultan, Bo Young Choi, Olatunji Ajiteru, Dae Ki Hong, Soon Min Lee, Hyo-Jin Kim, Jun Sun Ryu, Ji Seung Lee, Heesun Hong, Young Jin Lee, Hanna Lee, Ye Ji Suh, Ok Joo Lee, Soon Hee Kim, Sang Won Suh & Chan Hum Park. (2021) Reinforced-hydrogel encapsulated hMSCs towards brain injury treatment by trans-septal approach. Biomaterials 266, pages 120413.
Crossref
Mukta Agrawal, Aditya Narayan Konwar, Amit Alexander & Vivek Borse. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 305 328 .
Sanjay B. Patil. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 267 285 .
Wioletta Kazana & Agnieszka Zabłocka. (2020) Brain-derived neurotrophic factor as a potential therapeutic tool in the treatment of nervous system disorders. Postępy Higieny i Medycyny Doświadczalnej 74, pages 517-531.
Crossref
Tianyi Wang, Junyi Zhang, Peng Li, Yan Ding, Jiping Tang, Gang Chen & John H. Zhang. (2020) NT-4 attenuates neuroinflammation via TrkB/PI3K/FoxO1 pathway after germinal matrix hemorrhage in neonatal rats. Journal of Neuroinflammation 17:1.
Crossref
Catarina Miranda-Lourenço, Leonor Ribeiro-Rodrigues, João Fonseca-Gomes, Sara R. Tanqueiro, Rita F. Belo, Catarina B. Ferreira, Nádia Rei, Mafalda Ferreira-Manso, Carolina de Almeida-Borlido, Tiago Costa-Coelho, Céline Felicidade Freitas, Svitlana Zavalko, Francisco M. Mouro, Ana M. Sebastião, Sara Xapelli, Tiago M. Rodrigues & Maria J. Diógenes. (2020) Challenges of BDNF-based therapies: From common to rare diseases. Pharmacological Research 162, pages 105281.
Crossref
Laurent Martin, Julio Cesar Garcia Rodriguez, Michel Audran, Magnus Ericsson, Tangui Maurice & Alexandre Marchand. (2020) Detection of a nonerythropoietic erythropoietin, Neuro‐EPO, in blood after intranasal administration in rat. Drug Testing and Analysis 12:11-12, pages 1605-1613.
Crossref
Elena V. Grigor’eva, Tuyana B. Malankhanova, Aizhan Surumbayeva, Sophia V. Pavlova, Julia M. Minina, Elena A. Kizilova, Lyubov A. Suldina, Ksenia N. Morozova, Elena Kiseleva, Eugeny D. Sorokoumov, Igor N. Lebedev, Suren M. Zakian & Anastasia A. Malakhova. (2020) Generation of GABAergic striatal neurons by a novel iPSC differentiation protocol enabling scalability and cryopreservation of progenitor cells. Cytotechnology 72:5, pages 649-663.
Crossref
Jie Lin, Yusuke Niimi, Mariano Guardia Clausi, Hur Dolunay Kanal & Steven W. Levison. (2020) Neuroregenerative and protective functions of Leukemia Inhibitory Factor in perinatal hypoxic-ischemic brain injury. Experimental Neurology 330, pages 113324.
Crossref
Po-Chuan Chiu, Houng-Chi Liou, Thai-Yen Ling & Li-Jiuan Shen. (2020) Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood–Brain Barrier. Neurotherapeutics 17:3, pages 1184-1196.
Crossref
Daniela Mauceri, Bettina BuchthalThekla J. HemstedtUrsula WeissChristian D. Klein & Hilmar Bading. (2020) Nasally delivered VEGFD mimetics mitigate stroke-induced dendrite loss and brain damage. Proceedings of the National Academy of Sciences 117:15, pages 8616-8623.
Crossref
Qin Ding, Xianhe Zhang & Peng Chen. (2020) Intraoperative Dexmedetomidine in Peripheral or Emergency Neurologic Surgeries of Patients With Mild-to-Moderate Traumatic Brain Injuries: A Retrospective Cohort Study. Dose-Response 18:2, pages 155932582092011.
Crossref
Sun Ryu, Hyongjun Jeon, Hee-Young Kim, Sungtae Koo & Seungtae Kim. (2020) Korean red ginseng promotes hippocampal neurogenesis in mice. Neural Regeneration Research 15:5, pages 887.
Crossref
Dharani Manickavasagam, Li Lin & Moses O. Oyewumi. (2020) Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation. Nanomedicine: Nanotechnology, Biology and Medicine 23, pages 102107.
Crossref
Robin Ji, Morgan Smith, Yusuke Niimi, Maria E. Karakatsani, Maria F. Murillo, Vernice Jackson-Lewis, Serge Przedborski & Elisa E. Konofagou. (2019) Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson’s disease mouse model. Scientific Reports 9:1.
Crossref
R. J. Macias-Velez, L. Fukushima-Díaz de León, C. Beas-Zárate & M. C. Rivera-Cervantes. (2019) Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats. Journal of Molecular Neuroscience 68:4, pages 590-602.
Crossref
Ekaterina Shevela, Marina Davydova, Natalia Starostina, Alexandra Yankovskaya, Alexandr Ostanin & Elena Chernykh. (2019) Intranasal delivery of M2 macrophage-derived soluble products reduces neuropsychological deficit in patients with cerebrovascular disease: a pilot study. Journal of Neurorestoratology 7:2, pages 89-100.
Crossref
Noritaka Nakamichi, Yusuke Masuo & Yukio Kato. (2019) Possible Treatment of Neuropsychiatric Disorders by Promotion of Neuronal Differentiation through Organic Cation Transporters有機カチオン膜輸送体による神経幹細胞の機能制御と精神神経疾患治療への応用. YAKUGAKU ZASSHI 139:6, pages 847-852.
Crossref
Reas S. Khan, Kimberly Dine, Howard Wessel, Larry Brown & Kenneth S. Shindler. (2019) Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection. Journal of Neuro-Ophthalmology 39:2, pages 191-199.
Crossref
Yannan Bin, Qizhi Zhu, Menglu Li & Junfeng Xia. (2019) Comprehensive Analysis of Alzheimer’s Disease Biologically Candidate Causal Genes Revealed by Function Association Study With GWAS. IEEE Access 7, pages 114236-114245.
Crossref
Takahiro Ishimoto, Yusuke Masuo, Yukio Kato & Noritaka Nakamichi. (2019) Ergothioneine-induced neuronal differentiation is mediated through activation of S6K1 and neurotrophin 4/5-TrkB signaling in murine neural stem cells. Cellular Signalling 53, pages 269-280.
Crossref
Nazneen N. Dewji, Marc R. Azar, Leah R. Hanson, William H. Frey II, Bruce H. Morimoto & David Johnson. (2018) Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer’s Disease: Stability and Delivery to the Brain1. Journal of Alzheimer's Disease Reports 2:1, pages 169-179.
Crossref
Irfan Ullah, Kunho Chung, Jungju Oh, Jagadish Beloor, Sumin Bae, Sangah Clara Lee, Minhyung Lee, Priti Kumar & Sang-Kyung Lee. (2018) Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia. Scientific Reports 8:1.
Crossref
Bettina Buchthal, Ursula Weiss & Hilmar Bading. (2018) Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model. Molecular Therapy 26:10, pages 2357-2365.
Crossref
Nathalie Alvarez-Ricartes, Patricia Oliveros-Matus, Cristhian Mendoza, Nelson Perez-Urrutia, Florencia Echeverria, Alexandre Iarkov, George E. Barreto & Valentina Echeverria. (2018) Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice. Molecular Neurobiology 55:10, pages 7949-7960.
Crossref
Victor Silva da Fonsêca, André R. da Silva Colla, Cristine de Paula Nascimento-Castro, Evelini Plácido, Julia Macedo Rosa, Marcelo Farina, Joana Gil-Mohapel, Ana Lúcia S. Rodrigues & Patricia S. Brocardo. (2018) Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington’s Disease Mice. Molecular Neurobiology 55:9, pages 7201-7215.
Crossref
Eleni Samaridou & Maria José Alonso. (2018) Nose-to-brain peptide delivery – The potential of nanotechnology. Bioorganic & Medicinal Chemistry 26:10, pages 2888-2905.
Crossref
Gabriela A. Grinblat, Reas S. Khan, Kimberly Dine, Howard Wessel, Larry Brown & Kenneth S. Shindler. (2018) RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome. Investigative Opthalmology & Visual Science 59:6, pages 2470.
Crossref
Alberto de Bellis, Massimo de Bellis & Luigi Aloe. (2018) Long-Term Non-Invasive Treatment via Intranasal Administration of Nerve Growth Factor Protects the Human Brain in Frontotemporal Dementia associated with Corticobasal Syndrome: A Pilot Study. Journal of Alzheimer's Disease Reports 2:1, pages 67-77.
Crossref
Hiroki Tateiwa, Takashi Kawano, Atsushi Nishigaki, Daiki Yamanaka, Bun Aoyama, Marie Shigematsu-Locatelli, Satoru Eguchi, Fabricio M. Locatelli & Masataka Yokoyama. (2018) The role of hippocampal brain-derived neurotrophic factor in age-related differences in neuropathic pain behavior in rats. Life Sciences 197, pages 56-66.
Crossref
Yuhang Jiang, James M. Fay, Chi‐Duen Poon, Natasha Vinod, Yuling Zhao, Kristin Bullock, Si Qin, Devika S Manickam, Xiang Yi, William A. Banks & Alexander V. Kabanov. (2017) Nanoformulation of Brain‐Derived Neurotrophic Factor with Target Receptor‐Triggered‐Release in the Central Nervous System. Advanced Functional Materials 28:6, pages 1703982.
Crossref
Rhiannon Beard, Nisha Singh, Christophe Grundschober, Antony D. Gee & Edward W. Tate. (2018) High-yielding 18 F radiosynthesis of a novel oxytocin receptor tracer, a probe for nose-to-brain oxytocin uptake in vivo . Chemical Communications 54:58, pages 8120-8123.
Crossref
Tomohiro Umeda, Akiko Tanaka, Ayumi Sakai, Akira Yamamoto, Toshiyasu Sakane & Takami Tomiyama. (2018) Intranasal rifampicin for Alzheimer's disease prevention. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:1, pages 304-313.
Crossref
Vimala N. Bharadwaj, Duong T. Nguyen, Vikram D. Kodibagkar & Sarah E. Stabenfeldt. (2017) Nanoparticle‐Based Therapeutics for Brain Injury. Advanced Healthcare Materials 7:1, pages 1700668.
Crossref
Orestes Santos-Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez, Yaisel Pomares-Iturralde, Tatiana Festary-Casanovas, Carlos A. González-Delgado, Sonia Pérez-Rodríguez, Eulalia Alfonso-Muñoz, Carmen Viada-González, Patricia Piedra-Sierra, Idrian García-García, Daniel Amaro-González, Julio César García-Rodríguez, Iliana Sosa-Testé, Alicia Lagarto-Parra, Laura Barrero-Viera, Marlene David-Baldo, Maura Tamayo-Rodríguez, Ivonne Rivero-Vázquez, Gricel González-Gamiz, Alis Martín-Trujillo, Yasmila Rodríguez-Fernández, Ana Alfa Ledo-de la Luz, Maylén Álvarez-Delgado, Ivón Howland-Álvarez & Yolanda Cruz-Gómez. (2017) Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study. BMC Neurology 17:1.
Crossref
William M. Pardridge. (2017) Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology. BioDrugs 31:6, pages 503-519.
Crossref
Ming-Li Chou, Joe-Wei Wu, Flore Gouel, Aurélie Jonneaux, Kelly Tillerman, Ting-Yi Renn, Charlotte Laloux, Hung-Ming Chang, Liang-Tzung Lin, Jean-Christophe Devedjian, David Devos & Thierry Burnouf. (2017) Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease. Biomaterials 142, pages 77-89.
Crossref
Konstantinos Botsakis, Theodora Mourtzi, Vasiliki Panagiotakopoulou, Malamati Vreka, Georgios T. Stathopoulos, Iosif Pediaditakis, Ioannis Charalampopoulos, Achilleas Gravanis, Foteini Delis, Katerina Antoniou, Dimitrios Zisimopoulos, Christos D. Georgiou, Nikolaos T. Panagopoulos, Nikolaos Matsokis & Fevronia Angelatou. (2017) BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the “weaver” mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor. Neuropharmacology 121, pages 140-157.
Crossref
Xi-Chong Yu, Jing-Jing Yang, Bing-Hui Jin, He-Lin Xu, Hong-Yu Zhang, Jian Xiao, Cui-Tao Lu, Ying-Zheng Zhao & Wei Yang. (2017) A strategy for bypassing the blood-brain barrier: Facial intradermal brain-targeted delivery via the trigeminal nerve. Journal of Controlled Release 258, pages 22-33.
Crossref
Chiara Criscuolo, Carlotta Fabiani, Elisa Cerri & Luciano Domenici. (2017) Synaptic Dysfunction in Alzheimer’s Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection. Frontiers in Cellular Neuroscience 11.
Crossref
Reas S. Khan, Kimberly Dine, Bailey Bauman, Michael Lorentsen, Lisa Lin, Helayna Brown, Leah R. Hanson, Aleta L. Svitak, Howard Wessel, Larry Brown & Kenneth S. Shindler. (2017) Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model. Scientific Reports 7:1.
Crossref
Emine Sekerdag. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors 103 113 .
A. Gaudin, Y.-E. Seo, E. Song, E. Quijano, A.R. King & W.M. Saltzman. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II 549 570 .
Yamila Rodríguez Cruz, Manon Strehaiano, Teresita Rodríguez Obaya, Julío César García Rodríguez & Tangui Maurice. (2016) An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 55:1, pages 231-248.
Crossref
Lindsey Crawford, Justin Rosch & David Putnam. (2016) Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system. Journal of Controlled Release 240, pages 251-266.
Crossref
Yangyang Huang & Cheryl F. Dreyfus. (2016) The role of growth factors as a therapeutic approach to demyelinating disease. Experimental Neurology 283, pages 531-540.
Crossref
M. Guardia Clausi, P.M. Paez, L.A. Pasquini & J.M. Pasquini. (2016) Inhalation of growth factors and apo-transferrin to protect and repair the hypoxic-ischemic brain. Pharmacological Research 109, pages 81-85.
Crossref
Hong Chen, Georgiana Zong Xin Yang, Hoheteberhan Getachew, Camilo Acosta, Carlos Sierra Sánchez & Elisa E. Konofagou. (2016) Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Scientific Reports 6:1.
Crossref
Montserrat Serra-Millàs. (2016) Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?. World Journal of Psychiatry 6:1, pages 84.
Crossref
D S Quintana, A J Guastella, L T Westlye & O A Andreassen. (2015) The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders. Molecular Psychiatry 21:1, pages 29-38.
Crossref
Maartje S. Spetter & Manfred Hallschmid. (2015) Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease. Molecular Pharmaceutics 12:8, pages 2767-2780.
Crossref
Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos & Nathalie Faucheux. (2015) Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease. Journal of Controlled Release 206, pages 187-205.
Crossref
Caroline P. AddingtonAdam RoussasDipankar DuttaSarah E. Stabenfeldt. (2015) Endogenous Repair Signaling after Brain Injury and Complementary Bioengineering Approaches to Enhance Neural Regeneration. Biomarker Insights 10s1, pages BMI.S20062.
Crossref
Yufu Wang, Jing Li, Pengyu Kong, Song Zhao, Hui Yang, Chao Chen & Jinglong Yan. (2015) Enhanced Expression of Neurotrophic Factors in the Injured Spinal Cord Through Vaccination With Myelin Basic Protein-Derived Peptide Pulsed Dendritic Cells. Spine 40:2, pages 95-101.
Crossref
R. Castañeda-Arellano, A.I. Feria-Velasco & M.C. Rivera-Cervantes. (2014) Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats. Neuroscience Letters 583, pages 16-20.
Crossref
Jonathan K. Dozier, Santoshkumar L. Khatwani, James W. Wollack, Yen-Chih Wang, Claudia Schmidt-Dannert & Mark D. Distefano. (2014) Engineering Protein Farnesyltransferase for Enzymatic Protein Labeling Applications. Bioconjugate Chemistry 25:7, pages 1203-1212.
Crossref
Xinfeng Liu, Ruidong Ye, Tao Yan, Shan Ping Yu, Ling Wei, Gelin Xu, Xinying Fan, Yongjun Jiang, R. Anne Stetler, George Liu & Jieli Chen. (2014) Cell based therapies for ischemic stroke: From basic science to bedside. Progress in Neurobiology 115, pages 92-115.
Crossref
Joseph P. Steiner & Avindra Nath. (2014) Neurotrophin Strategies for Neuroprotection: Are They Sufficient?. Journal of Neuroimmune Pharmacology 9:2, pages 182-194.
Crossref
Chiara Zuccato & Elena Cattaneo. 2014. Neurotrophic Factors. Neurotrophic Factors 357 409 .
Angelina Angelova, Borislav Angelov, Markus Drechsler & Sylviane Lesieur. (2013) Neurotrophin delivery using nanotechnology. Drug Discovery Today 18:23-24, pages 1263-1271.
Crossref
Dianer Yang, Yu-Yo Sun, Xiaoyi Lin, Jessica M. Baumann, R. Scott Dunn, Diana M. Lindquist & Chia-Yi Kuan. (2013) Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic–ischemic brain injury. Experimental Neurology 247, pages 447-455.
Crossref
Lipa Shah, Sunita Yadav & Mansoor Amiji. (2013) Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Delivery and Translational Research 3:4, pages 336-351.
Crossref
Bai Lu, Guhan Nagappan, Xiaoming Guan, Pradeep J. Nathan & Paul Wren. (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature Reviews Neuroscience 14:6, pages 401-416.
Crossref
Sudheesh Pilakka-Kanthikeel, Venkata Subba Rao Atluri, Vidya Sagar, Shailendra K. Saxena & Madhavan Nair. (2013) Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study. PLoS ONE 8:4, pages e62241.
Crossref
Claire Géral, Angelina Angelova & Sylviane Lesieur. (2013) From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF). Pharmaceutics 5:4, pages 127-167.
Crossref
AI CHEN, LI-JING XIONG, YU TONG & MENG MAO. (2013) The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomedical Reports 1:2, pages 167-176.
Crossref
Mauro W. Zappaterra & Maria K. Lehtinen. (2012) The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond. Cellular and Molecular Life Sciences 69:17, pages 2863-2878.
Crossref
Andrew J. Shoffstall, Dawn M. Taylor & Erin B. Lavik. (2012) Engineering therapies in the CNS: What works and what can be translated. Neuroscience Letters 519:2, pages 147-154.
Crossref
Lucas Silvestroff, Sandra Bartucci, Juana Pasquini & Paula Franco. (2012) Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination. Experimental Neurology 235:1, pages 357-367.
Crossref
Jeffrey J. Lochhead & Robert G. Thorne. (2012) Intranasal delivery of biologics to the central nervous system. Advanced Drug Delivery Reviews 64:7, pages 614-628.
Crossref
V. Ott, C. Benedict, B. Schultes, J. Born & M. Hallschmid. (2011) Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes, Obesity and Metabolism 14:3, pages 214-221.
Crossref
Yuanfei Wang, Michael J. Cooke, Cindi M. Morshead & Molly S. Shoichet. (2012) Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 33:9, pages 2681-2692.
Crossref
Siva Ram Kiran Vaka, Sathyanarayana Narasimha Murthy, Anna Balaji & Michael A. Repka. (2011) Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway. Pharmaceutical Research 29:2, pages 441-447.
Crossref
Shih-Jen Tsai. (2012) Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: A possible approach for the treatment of Rett syndrome. Medical Science Monitor 18:8, pages HY33-HY36.
Crossref
Y. Jiang, N. Wei, J. Zhu, D. Zhai, L. Wu, M. Chen, G. Xu & X. Liu. (2012) A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain. Neuroscience 201, pages 96-104.
Crossref
Ihsan Solaroglu & Murat Digicaylioglu. 2012. Translational Stroke Research. Translational Stroke Research 251 276 .
Cornelia Demel, Tobias Hoegen, Armin Giese, Barbara Angele, Hans-Walter Pfister, Uwe Koedel & Matthias Klein. (2011) Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis. Journal of Neuroinflammation 8:1.
Crossref
Mats HellströmMargaret A. PollettAlan R. Harvey. (2011) Post-Injury Delivery of rAAV2-CNTF Combined with Short-Term Pharmacotherapy Is Neuroprotective and Promotes Extensive Axonal Regeneration after Optic Nerve Trauma. Journal of Neurotrauma 28:12, pages 2475-2483.
Crossref
Robert A. Scranton, Lauren Fletcher, Shane Sprague, David F. Jimenez & Murat Digicaylioglu. (2011) The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS. PLoS ONE 6:4, pages e18711.
Crossref
Yan Gao, Yuneidis Mengana, Yamila Rodríguez Cruz, Adriana Muñoz, Iliana Sosa Testé, Jorge Daniel García, Yonghong Wu, Julio César García Rodríguez & Chenggang Zhang. (2011) Different Expression Patterns of Ngb and EPOR in the Cerebral Cortex and Hippocampus Revealed Distinctive Therapeutic Effects of Intranasal Delivery of Neuro-EPO for Ischemic Insults to the Gerbil Brain. Journal of Histochemistry & Cytochemistry 59:2, pages 214-227.
Crossref
Y. Jiang, N. Wei, T. Lu, J. Zhu, G. Xu & X. Liu. (2011) Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 172, pages 398-405.
Crossref
Kamilla W. Miskowiak, Elisa Favaron, Sepehr Hafizi, Becky Inkster, Guy M. Goodwin, Philip J. Cowen & Catherine J. Harmer. (2010) Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology 210:3, pages 419-428.
Crossref
Elena Gomez de Barreda. (2010) Is tau a suitable therapeutical target in tauopathies?. World Journal of Biological Chemistry 1:5, pages 81.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.